🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
No Analytics: We do not use Google Analytics or any other tracking services.
Search Privacy: Your searches and filters are not logged or stored on our servers.
Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

The presence of a report does not mean the vaccine caused the adverse event.
Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
Serious adverse events must be reported by law, even if unrelated to the vaccine.
The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death

🏥 Hospitalized

🚑 Emergency Room

♿ Disability

⚠️ Life Threatening

How to Search

💡 Search Tips:

Select Year: Choose a specific year OR "All Years" to search across all data
All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
VAERS ID: Search for specific report by ID number
Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
State: Enter 2-letter state code (e.g., CA, NY, TX)
Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
Lot Number: Search specific vaccine lot (works great with "All Years")
Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

Reports are unverified: VAERS accepts all reports without medical verification
Not proof of causation: A report does not mean the vaccine caused the event
Anyone can report: Healthcare providers, patients, and family members can submit reports
Multiple vaccines: One report may list multiple vaccines given at the same time
Blank fields: Not all fields are required, so some data may be missing

Using the Table

Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
Expand text: Click "More" to see full narrative or symptom text
Navigate pages: Use pagination controls at top and bottom of table
Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.

34,052

Total Reports (2025)

500

Deaths Reported

1,634

Hospitalizations

ER Visits

1,191

Disabilities

570

Life Threatening

Year: VAERS ID: Age: Sex: State: Vaccine Type: Manufacturer: Lot Number: Site: Symptom: Death: Hospitalized:

🔄 Reset 📥 Export CSV

Showing 28,801 to 28,850 of 34,052 reports (Page 577 of 682)

« First ‹ Prev 1 ... 574 575 576 577 578 579 580 ... 682 Next › Last »

ID	Age	Sex	State	Date ▼	Vaccine	Manufacturer	Lot #	Symptoms	Narrative	🏥	♿	⚠️
2700946		U	NM	11/14/2024	COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 COVID19	PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH	EL9261 EL9261 EL9261 EL9261 ENG201 ENG201 ENG201 ENG201	COVID-19, Drug ineffective, Near death experience; Chest pain, Dizziness, Echoca... COVID-19, Drug ineffective, Near death experience; Chest pain, Dizziness, Echocardiogram, Electrocardiogram, Exercise tolerance decreased; Fatigue, Headache, Laboratory test, Nausea, Pain in extremity; Palpitations, Pleuritic pain, Postural orthostatic tachycardia syndrome, Pyrexia, Small fibre neuropathy; X-ray; Chest pain, Dizziness, Echocardiogram, Electrocardiogram, Exercise tolerance decreased; Fatigue, Headache, Laboratory test, Nausea, Pain in extremity; Palpitations, Pleuritic pain, Postural orthostatic tachycardia syndrome, Pyrexia, Small fibre neuropathy; X-ray; Illness, Impaired work ability, Loss of personal independence in daily activities, Near death experience, Quality of life decreased More	I had the Delta variant in Jul; I had the Delta variant in Jul; I've cheated death three times ... I had the Delta variant in Jul; I had the Delta variant in Jul; I've cheated death three times now; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (disability, life threatening), COVID-19 (disability, life threatening), outcome "unknown" and all described as "I had the Delta variant in Jul"; NEAR DEATH EXPERIENCE (disability, life threatening), outcome "unknown", described as "I've cheated death three times now". Clinical Course: Description of Event Outcome: Patient was having severe physical disabilities ever since 2021. Patient had two Pfizer vaccines, which didn't go well, had the Delta variant in Jul. Patient had cheated death three times now, so disabled patient can't even work. This was extremely difficult on patient and patient beg to help, (name withheld). More		✓	✓
2619083	71	F	NY	04/21/2023	UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK COVID19	UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER PFIZER\BIONTECH	EW0185 EW0191 EW0185 EW0191 EW0185 EW0191 EW0185 EW0191 EW0185 EW0191 EW0191 EW0191 EW0191 EW0191 EW0191	Asthenia, Balance disorder, Blood pressure decreased, Blood pressure increased, ... Asthenia, Balance disorder, Blood pressure decreased, Blood pressure increased, Condition aggravated; Crying, Depression, Dizziness postural, Dyspnoea, Emotional disorder; Fear, Headache, Heart rate increased, Impaired quality of life, Malaise; Migraine, Myalgia, Postural orthostatic tachycardia syndrome, Pulmonary function test, Tachycardia; Tremor, Vertigo; Asthenia, Balance disorder, Blood pressure decreased, Blood pressure increased, Condition aggravated; Crying, Depression, Dizziness postural, Dyspnoea, Emotional disorder; Fear, Headache, Heart rate increased, Impaired quality of life, Malaise; Migraine, Myalgia, Postural orthostatic tachycardia syndrome, Pulmonary function test, Tachycardia; Tremor, Vertigo; Anxiety, Cardiac disorder More	POTS LIKE SYMPTOMS MAJOR DROP IN BP 10-60 POINT WHEN GETTING UP FROM LYING DOWN OR SITTING TACCHARDI... POTS LIKE SYMPTOMS MAJOR DROP IN BP 10-60 POINT WHEN GETTING UP FROM LYING DOWN OR SITTING TACCHARDIA IF JUST MAKE BED OR VACCCUUM BLOOD PRESSURE AND PULSE UP.......ON BETA BLOCKERS NEVER THE CASE BEFORE WORSE HEADACHES MUSCLE PAINS SOB EXTREMELY BAD NOW PRESSURE FIRST TIME LOW AT TIMES AS LOW AS 88/38 AS HIGH AS 197/100 UPON WAKING AND OCCAS DURING DAY. NEVER HAPPENED BEFORE UNLESS HAVING PANIC ATTACK. EXTREME WORSENING OF DEPRESSION.EMOTIONAL AND CRY OFTEN. VERTIGO DIZZY IF GET UP AND DO NOT WAIT A MINUTE. OFF BALANCE. MY SLIGHT TREMOR MORE PRONOUNDED AT TIMES,HOME OFTEN NO STAMINA NO LIFE SO SCARRY.........I NEVER WANTED TO TAKE BUT HAD TO FLY More		✓
2827584		F	GA	02/21/2025	COVID19	PFIZER\BIONTECH		Aphasia, Pain in extremity, Pneumothorax, Pulmonary thrombosis, Swelling Aphasia, Pain in extremity, Pneumothorax, Pulmonary thrombosis, Swelling	left lung collapsed due to a small clot like those from birth control pills; pulmonary thrombosis; a... left lung collapsed due to a small clot like those from birth control pills; pulmonary thrombosis; aphasia; the top of it feels tight. She can press it (even squeeze it) and it hurts a little bit; noticed some swelling near her breast underneath the armpit; This is a spontaneous report received from a Nurse from medical information team, Program ID. A 79-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose 2, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 nos (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "aphasia", "noticed some swelling near her breast underneath the armpit", "the top of it feels tight. She can press it (even squeeze it) and it hurts a little bit", "left lung collapsed due to a small clot like those from birth control pills". The following information was reported: PNEUMOTHORAX (medically significant), outcome "unknown", described as "left lung collapsed due to a small clot like those from birth control pills"; APHASIA (non-serious), outcome "unknown"; BREAST SWELLING (non-serious), outcome "unknown", described as "noticed some swelling near her breast underneath the armpit"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "the top of it feels tight. She can press it (even squeeze it) and it hurts a little bit". Clinical course: The first vaccine that the reporter had was some years ago and she had aphasia. Her left lung collapsed due to a small clot like those from birth control pills. Then, a few months later, she noticed some swelling near her breast underneath the armpit. It doesn't go away. For the next dose of the COVID-19 vaccine, the same thing happened to her right arm. Now, the top of it feels tight. She can press it (even squeeze it) and it hurts a little bit. Caller would like to get them removed. The caller is a retired nurse calling for herself as she took her first covid shot on her left arm and had a reaction and next shot is on her right arm and had the same reaction, and now unable to fit on her coat. Caller is asking if she can get the next shot on her hip or she will do it by herself as she knew how to do it. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the events pneumothorax, and pulmonary thrombosis and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate. More
2827585		M	NJ	02/21/2025	COVID19	UNKNOWN MANUFACTURER		Pre-existing condition improved, Therapeutic response unexpected Pre-existing condition improved, Therapeutic response unexpected	got the Pfizer COVID-19 shot, patient was feeling a lot better. Confirmed had asthma prior to gettin... got the Pfizer COVID-19 shot, patient was feeling a lot better. Confirmed had asthma prior to getting the Pfizer COVID-19 shot; got the Pfizer COVID-19 shot, patient was feeling a lot better. Confirmed had asthma prior to getting the Pfizer COVID-19 shot; This is a spontaneous report received from a Consumer or other non HCP. A male patient received BNT162b2 omicron (kp.2) (BNT162B2 OMICRON (KP.2)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "hospitalized" (unspecified if ongoing), notes: every month. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 omicron (kp.2) (DOSE 1, SINGLE), for Covid 19 immunization, reaction(s): "was suffering from asthma, after got the Pfizer COVID-19 shot, is feeling a lot better", "was suffering from asthma, after got the Pfizer COVID-19 shot, is feeling a lot better". The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), PRE-EXISTING CONDITION IMPROVED (non-serious), outcome "unknown" and all described as "got the Pfizer COVID-19 shot, patient was feeling a lot better. Confirmed had asthma prior to getting the Pfizer COVID-19 shot". Additional information: Caller's friend, marked as patient, also was suffering from asthma, and caller's friend used to get hospitalized every month. After caller's friend got the Pfizer COVID-19 shot, caller's friend is feeling a lot better. Confirmed had asthma prior to getting the Pfizer COVID-19 shot. Caller stated Pfizer had the best reputation, and then caller got the second shot because was very good for asthma, which was the same for caller's friend who was worse. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2827586		M		02/21/2025	PNC20	PFIZER\WYETH		Pain in extremity Pain in extremity	received the Prevnar vaccine and he was actually fine and he just said that he had soreness in arm; ... received the Prevnar vaccine and he was actually fine and he just said that he had soreness in arm; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 66-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single, in arm for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "received the Prevnar vaccine and he was actually fine and he just said that he had soreness in arm". Additional information: The reporter was now asking for Prevnar 20. The reporter mentioned that her husband got the Pfizer Prevnar shot through (redacted) and was fine but has a wonderful immune system and allergic to nothing. The reporter informed that she was considering the same shot for her son. More
2827587			TX	02/21/2025	COVID19	PFIZER\BIONTECH	FL3198	Pain in extremity Pain in extremity	sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old pat... sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old patient received BNT162b2 (BNT162B2), in Apr2020 as dose 1, single (Lot number: FL3198) for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing); "cataracts are forming over the last few years" (ongoing); "Penicillin allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "tetracycline allergy" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "allergies" (unspecified if ongoing); "deaf/profound hearing loss" (ongoing), notes: 50+ years; "Wore oticon 380P hearing aids" (ongoing). Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; CLARITIN [CLARITHROMYCIN]. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500021060 same patient/product/event; different dose; More
2827588			TX	02/21/2025	COVID19	PFIZER\BIONTECH	EP6955	Inappropriate schedule of product administration, Pain in extremity Inappropriate schedule of product administration, Pain in extremity	sore arm; inappropriate schedule of vaccine administered; This is a spontaneous report received from... sore arm; inappropriate schedule of vaccine administered; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old patient received BNT162b2 (BNT162B2), on 27Mar2021 as dose 2, single (Lot number: EP6955) for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing); "cataracts are forming over the last few years" (ongoing); "Penicillin allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "tetracycline allergy" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "allergies" (unspecified if ongoing); "deaf/profound hearing loss" (ongoing), notes: 50+ years; "Wore oticon 380P hearing aids" (ongoing). Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; CLARITIN [CLARITHROMYCIN]. Vaccination history included: Biontech (dose 1; lot: FL3198), administration date: Apr2020, for covid-19 immunization, reaction(s): "sore arm". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 27Mar2021, outcome "unknown", described as "inappropriate schedule of vaccine administered"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500021060 same patient/product/event; different dose; More
2827589			TX	02/21/2025	COVID19	PFIZER\BIONTECH	EW0162	Pain in extremity Pain in extremity	sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old pat... sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old patient received BNT162b2 (BNT162B2), on 19Apr2021 as dose 3 (booster), single (Lot number: EW0162), for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing); "cataracts are forming over the last few years" (ongoing); "Penicillin allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "tetracycline allergy" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "allergies" (unspecified if ongoing); "deaf/profound hearing loss" (ongoing), notes: 50+ years; "Wore oticon 380P hearing aids" (ongoing). Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; CLARITIN [CLARITHROMYCIN]. Vaccination history included: BNT162b2 (Dose 2; Lot: EP6955), administration date: 27Mar2021, for covid-19 immunization, reaction(s): "sore arm"; Biontech (dose 1; lot: FL3198), administration date: Apr2020, for covid-19 immunization, reaction(s): "sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500021060 same patient/product/event; different dose; More
2827590			TX	02/21/2025	COVID19	PFIZER\BIONTECH	GH9703	Pain in extremity Pain in extremity	sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old pat... sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Oct2022 as dose 4 (booster), single (Lot number: GH9703) for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing); "cataracts are forming over the last few years" (ongoing); "Penicillin allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "tetracycline allergy" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "allergies" (unspecified if ongoing); "deaf/profound hearing loss" (ongoing), notes: 50+ years; "Wore oticon 380P hearing aids" (ongoing). Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; CLARITIN [CLARITHROMYCIN]. Vaccination history included: BNT162b2 (Dose 2; Lot: EP6955), administration date: 27Mar2021, for covid-19 immunization, reaction(s): "sore arm"; BNT162b2 (Dose 3; lot: EW0162), administration date: 19Apr2021, for covid-19 immunization, reaction(s): "sore arm"; Biontech (dose 1; lot: FL3198), administration date: Apr2020, for covid-19 immunization, reaction(s): "sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500021060 same patient/product/event; different dose; More
2827591			TX	02/21/2025	COVID19	PFIZER\BIONTECH	HD9876	Pain in extremity Pain in extremity	sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old pat... sore arm; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 04Oct2023 as dose 1, single (Lot number: HD9876) for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing); "cataracts are forming over the last few years" (ongoing); "Penicillin allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "tetracycline allergy" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "allergies" (unspecified if ongoing); "deaf/profound hearing loss" (ongoing), notes: 50+ years; "Wore oticon 380P hearing aids" (ongoing). Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; CLARITIN [CLARITHROMYCIN]. Vaccination history included: BNT162b2 (Dose 2; Lot: EP6955), administration date: 27Mar2021, for covid-19 immunization, reaction(s): "sore arm"; BNT162b2 (Dose 3; lot: EW0162), administration date: 19Apr2021, for covid-19 immunization, reaction(s): "sore arm"; bivalent (Dose 4; lot: GH9703), administration date: 12Oct2022, for covid-19 immunization, reaction(s): "sore arm"; Biontech (dose 1; lot: FL3198), administration date: Apr2020, for covid-19 immunization, reaction(s): "sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500021060 same patient/product/event; different dose; More
2827592	59	F	NJ	02/21/2025	PNC20	PFIZER\WYETH	HP7365	Erythema, Pain, Peripheral swelling, Pruritus, Skin warm Erythema, Pain, Peripheral swelling, Pruritus, Skin warm	arm swelling; itching; redness; pain; hot to the touch; This is a spontaneous report received from a... arm swelling; itching; redness; pain; hot to the touch; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. A 59-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 09Jan2025 as dose 1, single (Lot number: HP7365) at the age of 59 years for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 14Jan2025, outcome "recovered" (18Jan2025), described as "arm swelling"; FEELING HOT (non-serious) with onset 14Jan2025, outcome "recovered" (18Jan2025), described as "hot to the touch"; PRURITUS (non-serious) with onset 14Jan2025, outcome "recovered" (18Jan2025), described as "itching"; PAIN (non-serious) with onset 14Jan2025, outcome "recovered" (18Jan2025); ERYTHEMA (non-serious) with onset 14Jan2025, outcome "recovered" (18Jan2025), described as "redness". It was unknown if therapeutic measures were taken as a result of peripheral swelling, pruritus, erythema, pain, feeling hot. Additional information: The vaccine was administered in the upper deltoid. The patient did not receive any other vaccines on the same date and within 4 weeks prior to pneumococcal 20-val conj vac (dipht crm197 protein). More
2827594	27	F	CA	02/21/2025	COVID19	PFIZER\BIONTECH	EW0183	Epilepsy, Seizure Epilepsy, Seizure	seizures / epilepsy; seizures / epilepsy; This is a spontaneous report received from a Consumer or o... seizures / epilepsy; seizures / epilepsy; This is a spontaneous report received from a Consumer or other non HCP. A 27-year-old female patient received BNT162b2 (BNT162B2), on 18May2021 as dose 2, single (Lot number: EW0183) at the age of 27 years intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: LAMOTRIGINE taken for anxiety. Vaccination history included: BNT162b2 (Dose 1, Single, Intramuscular, Batch number: EV0175, in the AM), administration date: 27Apr2021, when the patient was 27-year-old, for Covid-19 Immunization, reaction(s): "Seizures", "Epilepsy". The following information was reported: SEIZURE (disability) with onset 19May2021, outcome "not recovered", EPILEPSY (disability), outcome "unknown" and all described as "seizures / epilepsy". The event "seizures / epilepsy" required physician office visit. Therapeutic measures were taken as a result of epilepsy, seizure which included Keppra 3000 mg, Lamictal 200mg, Vimpat 400mg, Onfi 40 mg.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202400161429 Same patient, product and event different dose; More		✓
2827597			CO	02/21/2025	COVID19	PFIZER\BIONTECH		COVID-19, Drug ineffective COVID-19, Drug ineffective	I had a mild case; I had a mild case; This is a spontaneous report received from a Consumer or other... I had a mild case; I had a mild case; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "immunocompromised" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I had a mild case". Clinical course: The reporter stated that he was a healthcare worker, who has asthma, and the Pfizer COVID vaccine prevented hospitalization when caught COVID. Had a mild case, and strongly believe that may have died without the vaccine. Withheld is a former drug addict, and he lacks medical and science education and training. Please fight and stand up for immunocompromised people like me. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2827604	50	F	CA	02/21/2025	COVID19	PFIZER\BIONTECH		Headache, Illness, Influenza like illness Headache, Illness, Influenza like illness	sick; it made her feel like she had the flu; headaches; This is a spontaneous report received from a... sick; it made her feel like she had the flu; headaches; This is a spontaneous report received from a Nurse from medical information team. A 50-year-old female patient received BNT162b2 (BNT162B2), on 08Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 50 years, in right deltoid for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (ongoing), notes: Diagnosed at least 15 years ago. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 18Jan2021, when the patient was 50-year-old, for Covid-19 immunization, reaction(s): "headaches", "it made her feel like she had the flu", "sick". The following information was reported: HEADACHE (non-serious) with onset 09Feb2021, outcome "recovered", described as "headaches"; INFLUENZA LIKE ILLNESS (non-serious) with onset 09Feb2021, outcome "recovered", described as "it made her feel like she had the flu"; ILLNESS (medically significant) with onset 09Feb2021, outcome "recovered" (12Feb2021), described as "sick". The second dose made her sicker than the first. The event sick was reported as serious as other medically important condition. The reporter relatedness of drug to reaction/events was yes. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Given the compatible time association, the reasonable possibility that the reported events are related to BNT162b2 (BNT162B2) administration cannot be excluded. This case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators as appropriate.,Linked Report(s) : US-PFIZER INC-202500039043 same reporter/patient/event, different dose; More
2827605	51	F	MI	02/21/2025	COVID19	MODERNA	3043501	Extra dose administered, No adverse event Extra dose administered, No adverse event	Patient was given a vaccine she was not due for. Moderna Covid-19 12+ was administered for the 2nd ... Patient was given a vaccine she was not due for. Moderna Covid-19 12+ was administered for the 2nd time this season. Patient was actually due for a PCV20 vaccine. Patient did not report any adverse reaction. More
2827606	55	F	TN	02/21/2025	COVID19 COVID19 COVID19 COVID19 COVID19	PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH	FE3592 FE3592 FE3592 FE3592 FE3592	Alopecia, Antinuclear antibody, Arthralgia, Blood lactic acid, Brain fog; Chest ... Alopecia, Antinuclear antibody, Arthralgia, Blood lactic acid, Brain fog; Chest pain, Colonoscopy, Computerised tomogram abdomen, Dyspepsia, Dyspnoea; Electrocardiogram, Erythema, Exercise tolerance decreased, Fatigue, Full blood count; Haematology test, Metabolic function test, Pain, Pyrexia, Rash; Red blood cell sedimentation rate, Rheumatoid factor, Weight decreased, X-ray of pelvis and hip More	Fever 103 for several Mos. Whole body turned bright red. Shortness of breath and chest pain. Dige... Fever 103 for several Mos. Whole body turned bright red. Shortness of breath and chest pain. Digestion shut down for several Mos, losing 20 lbs, got down to 88 lbs. Body aches and severe joint pain. Hair fell out. Extreme brain fog. Skin rashes. Exertional intolerance. Fatigue. More		✓	✓
2827624	80	F	KS	02/21/2025	VARZOS	GLAXOSMITHKLINE BIOLOGICALS	94SE2	Extra dose administered, No adverse event Extra dose administered, No adverse event	No adverse events/problems reported by patient. Patient came in to get "second" dose and ... No adverse events/problems reported by patient. Patient came in to get "second" dose and it was discovered that the last dose was actually the patient's third dose of Shingrix. More
2827625	50	F	CA	02/21/2025	PNC20 PNC20	PFIZER\WYETH PFIZER\WYETH	LG5579 LG5579	Chest discomfort, Chest pain, Dizziness, Dyspnoea, Hot flush; Injection site pai... Chest discomfort, Chest pain, Dizziness, Dyspnoea, Hot flush; Injection site pain More	Adverse events included: hot flash, trouble breathing, chest pain/ tightness, injection site burning... Adverse events included: hot flash, trouble breathing, chest pain/ tightness, injection site burning, light headedness. Pt called her MD for recommendation during onset of symptoms. While seating in the vaccine area, patient was given water, glucose tablet. Then patient felt ok and left the pharmacy ~ 11:28 am. Pharmacy tried to contact patient after 3 times, leaving voicemail but with no response. More
2827626	5	M	CA	02/21/2025	HEPA IPV	GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR	22GP3 w1c83	Breath holding, Musculoskeletal stiffness, Staring; Breath holding, Musculoskele... Breath holding, Musculoskeletal stiffness, Staring; Breath holding, Musculoskeletal stiffness, Staring More	Patient's body was very stiff, and he had a blank stare right after receiving havrix and ipv va... Patient's body was very stiff, and he had a blank stare right after receiving havrix and ipv vaccines, he was seen by a doctor right after who attested that he is fine. Mother told us after the event that child has breath holding spells and that happen many times before. More
2827627	1.75	F	IA	02/21/2025	COVID19 COVID19 COVID19 COVID19	MODERNA PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH	AU5551B FT9142 FT9142 FT9142	Blood test, Colitis ulcerative, Colonoscopy, Diarrhoea; Blood test, Colitis ulce... Blood test, Colitis ulcerative, Colonoscopy, Diarrhoea; Blood test, Colitis ulcerative, Colonoscopy, Diarrhoea; Blood test, Colitis ulcerative, Colonoscopy, Diarrhoea; Blood test, Colitis ulcerative, Colonoscopy, Diarrhoea More	Child started showing signs of extreme diarrhea--frequency and intensity at the beginning of 2023. ... Child started showing signs of extreme diarrhea--frequency and intensity at the beginning of 2023. After consultation and tests with GI specialist, was diagnosed with ulcerative colitis. More
2827628	4	M		02/21/2025	DTAPIPV DTAPIPV	GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS		Axillary pain, Chills, Injection site erythema, Oedema peripheral, Pain; Pyrexia... Axillary pain, Chills, Injection site erythema, Oedema peripheral, Pain; Pyrexia, Swelling More	Per ED note: patient received a combo shot (Tdap/polio) on Friday and afterwards the injection site ... Per ED note: patient received a combo shot (Tdap/polio) on Friday and afterwards the injection site was red. On Saturday was complaining of soreness and today mother noted a painful bump to the L axilla with swelling extending to the L chest. per parent also with fever and chills. a similar thing happened with Kinrix and MMRV at prior administration. Patient was discharged from ED symptoms self resolved. More
2827629	42	F	OH	02/21/2025	COVID19 COVID19 COVID19 COVID19 COVID19 COVID19	MODERNA MODERNA MODERNA MODERNA MODERNA MODERNA	006B21A 006B21A 006B21A 006B21A 006B21A 006B21A	Aortic dilatation, Arthralgia, Biopsy peripheral nerve, Bladder dysfunction, Bli... Aortic dilatation, Arthralgia, Biopsy peripheral nerve, Bladder dysfunction, Blindness transient; Blood test, Chest pain, Cognitive disorder, Computerised tomogram, Dehydration; Dyspnoea, Exercise tolerance decreased, Fatigue, Left ventricular dilatation, Magnetic resonance imaging; Monoplegia, Muscular weakness, Myalgia, Nephrolithiasis, Oedema; Poor peripheral circulation, Postural orthostatic tachycardia syndrome, Pulmonary mass, Thrombosis, Tilt table test; Vasculitis More	Horrific chest pain, paralysis of leg, vasculitis, aortic dialation, dilated left ventricular of hea... Horrific chest pain, paralysis of leg, vasculitis, aortic dialation, dilated left ventricular of heart, muscle weakness, overwelming fatigue, temporary loss of vision, joint and muscle pain, blood pooling in hands and feet, blood clotting, extreme loss of cognitive function, inability to exercise. Shortness of breath, kidney stones, edema, chronic dehydration, bladder dysfunction, lung nodules, pots More		✓
2827630	65	F	FL	02/21/2025	VARZOS	GLAXOSMITHKLINE BIOLOGICALS	x4535	Cellulitis, Malaise, Pyrexia, Vomiting Cellulitis, Malaise, Pyrexia, Vomiting	Patient states she was sick for 10 days after receiving the shot with fever and vomiting. She states... Patient states she was sick for 10 days after receiving the shot with fever and vomiting. She states she contracted cellulitis approx 4-5 days after the shot. More
2827631	58	F	WA	02/21/2025	COVID19 COVID19 PNC20 PNC20	PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\WYETH PFIZER\WYETH		Disorientation, Dizziness, Migraine, Pain, Photophobia; Pyrexia; Disorientation,... Disorientation, Dizziness, Migraine, Pain, Photophobia; Pyrexia; Disorientation, Dizziness, Migraine, Pain, Photophobia; Pyrexia More	Dizziness, disorientation, body aches onset approximately 1230 AM 2/21/25; migraine with severe ligh... Dizziness, disorientation, body aches onset approximately 1230 AM 2/21/25; migraine with severe light sensitivity onset approximately 345 AM 2/21/25; fever onset approximately 9 AM 2/21/25. AA symptoms continuing through the time of this report 739 PM 2/21/25. All times are PST. More
2827632	0.5	M	IA	02/21/2025	FLU3 FLU3	GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS		Blepharospasm, Computerised tomogram normal, Electroencephalogram normal, Eye mo... Blepharospasm, Computerised tomogram normal, Electroencephalogram normal, Eye movement disorder, Gaze palsy; Posture abnormal, Streptococcus test negative More	Within 2 days of his first dose of flu shot, patient began demonstrating random eye rolling/flutteri... Within 2 days of his first dose of flu shot, patient began demonstrating random eye rolling/fluttering and would also tilt his head up and have an upward gaze. There was nothing in particular that onset these episodes. They were very sporadic, lasting only a few minutes, but could be hours apart or minutes apart. We told our doctor and he asked to see patient to evaluate. We showed 2 videos as evidence. Doctor spoke with neurologists at the University Hospital and they asked to see the videos. I emailed them and they called to say they wanted to do and EEG, so we went 2 days later for the scan and evaluation. More
2827633	69	F	MI	02/21/2025	VARZOS	GLAXOSMITHKLINE BIOLOGICALS		Fatigue, Injection site pain, Pruritus, Rash, Somnolence Fatigue, Injection site pain, Pruritus, Rash, Somnolence	SEVERE ITCHING & RASH up & down bottom-third of spine, can feel raised little spots / bumps ... SEVERE ITCHING & RASH up & down bottom-third of spine, can feel raised little spots / bumps on skin up & down spine. SOME, LESSER ITCHING & RASH along bottom edge(s) of rib cage, front, right & left sides. BEGAN WITHIN 48 HRS of vaccination. CURRENTLY, 8 DAYS SINCE VACCINATION, with no relief. OTHER, VERY MILD SYMPTOMS: pain at injection site for a few days, nothing extreme. EXTREME FATIGUE & SLEEPINESS, onset approximately 6-8 hrs after vaccination and lasting 48+ hours. Recommended on 02/21/2025 by pharmacist to try OTC products for itching and if itching & rash still present on 02/24/2025, to contact PCP. More
2827634	0.75	M	IA	02/21/2025	FLU3 FLU3	GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS		Balance disorder, Blepharospasm, Computerised tomogram normal, Gaze palsy, Postu... Balance disorder, Blepharospasm, Computerised tomogram normal, Gaze palsy, Posture abnormal; Seizure like phenomena, Streptococcus test negative More	The day after his 2nd dose of the flue shot vaccine, patient experienced similar seizure like activi... The day after his 2nd dose of the flue shot vaccine, patient experienced similar seizure like activity as he did after his first dose 2 months prior. This time, however, he was throwing his head back with more force, he was sticking his tongue out (new compared to last time), eyes would roll back and eyelids flutter. He would have his head tipped back so far, it would cause him to lose his balance. These episodes lasted for a few seconds, and were happened much more frequently than they did the first time, so we decided to go to the ER. More
2827745	28	F	KY	02/21/2025	MMR VARCEL	MERCK & CO. INC. MERCK & CO. INC.	Y005808 Y004554	Injection site erythema, Injection site swelling, Injection site warmth; Injecti... Injection site erythema, Injection site swelling, Injection site warmth; Injection site erythema, Injection site swelling, Injection site warmth More	Area around the site of the Varicella injection, red, swollen approximate size of a grapefruit, warm... Area around the site of the Varicella injection, red, swollen approximate size of a grapefruit, warm to touch. No itching. Patient states she had taken Benadryl, elevated left arm and ice to the area the evening of 2/19/25. Patient was going to continue the Benadryl, ice and elevate and if not better in 24-36 hrs, going to see HCP. More
2827150		F		02/20/2025	RSV	GLAXOSMITHKLINE BIOLOGICALS	UNK	Erythema, Fatigue, Headache Erythema, Fatigue, Headache	Erythema; fatigue; headache; This non-serious case was reported by a consumer via sales rep and desc... Erythema; fatigue; headache; This non-serious case was reported by a consumer via sales rep and described the occurrence of erythema in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received the 1st dose of Arexvy (unknown arm). On an unknown date, an unknown time after receiving Arexvy, the patient experienced erythema (Verbatim: Erythema), fatigue (Verbatim: fatigue) and headache (Verbatim: headache). The outcome of the erythema, fatigue and headache were resolved. The reporter considered the erythema, fatigue and headache to be related to Arexvy. The company considered the erythema, fatigue and headache to be related to Arexvy. Additional Information: GSK Receipt Date: 14-FEB-2025 The patient received Arexvy and had erythema, fatigue, headache. More
2827151	1.25	M	CA	02/20/2025	FLU3	GLAXOSMITHKLINE BIOLOGICALS	DJ22N	Incorrect route of product administration Incorrect route of product administration	administered a dose of FluLaval via subcutaneous route instead of intramuscular; This non-serious ca... administered a dose of FluLaval via subcutaneous route instead of intramuscular; This non-serious case was reported by a other health professional via call center representative and described the occurrence of intramuscular formulation administered by other route in a 15-month-old male patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (batch number DJ22N, expiry date 13-JUN-2025) for prophylaxis. On 22-JAN-2025, the patient received FluLaval 2024-2025 season (subcutaneous). On 22-JAN-2025, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced intramuscular formulation administered by other route (Verbatim: administered a dose of FluLaval via subcutaneous route instead of intramuscular). The outcome of the intramuscular formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-JAN-2025 Medical assistant reported a patient was administered a dose of FluLaval via subcutaneous route instead of intramuscular on the day of reporting, which led to an intramuscular formulation administered by other route. At the time of reporting, a repeat dose had not been administered. The vaccine administration facility was the same as primary reporter. More
2827152		F	KY	02/20/2025	MENB	NOVARTIS VACCINES AND DIAGNOSTICS		Back pain, Decreased appetite, Dizziness, Headache, Pyrexia Back pain, Decreased appetite, Dizziness, Headache, Pyrexia	Fever of 103 fahrenheit; Loss of appetite; Dizziness; Headache; Back pain; This non-serious case was... Fever of 103 fahrenheit; Loss of appetite; Dizziness; Headache; Back pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who received Men B NVS (Bexsero) for prophylaxis. The patient's past medical history included cerebral palsy (The patient had a medical history). On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced fever (Verbatim: Fever of 103 fahrenheit), appetite lost (Verbatim: Loss of appetite), dizziness (Verbatim: Dizziness), headache (Verbatim: Headache) and back pain (Verbatim: Back pain). The outcome of the fever, appetite lost, dizziness, headache and back pain were unknown. It was unknown if the reporter considered the fever, appetite lost, dizziness, headache and back pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the fever, appetite lost, dizziness, headache and back pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JAN-2025 and 30-JAN-2025 The patient experienced Fever of 103 fahrenheit, back pain, headache, dizziness, and loss of appetite after receiving the dose of Bexsero. The reporter did not consent to follow-up. More
2827153	64	M	NJ	02/20/2025	RSV	GLAXOSMITHKLINE BIOLOGICALS		Dizziness, Injection site pain, Syncope Dizziness, Injection site pain, Syncope	pain at injection site; dizzy; had syncope; This serious case was reported by a consumer via call ce... pain at injection site; dizzy; had syncope; This serious case was reported by a consumer via call center representative and described the occurrence of syncope in a 64-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On 06-FEB-2025, the patient received the 1st dose of Arexvy (left arm). In FEB-2025, 3 hrs after receiving Arexvy, the patient experienced syncope (Verbatim: had syncope) (serious criteria GSK medically significant), injection site pain (Verbatim: pain at injection site) and dizziness (Verbatim: dizzy). In FEB-2025, the outcome of the injection site pain was resolved. The outcome of the syncope was unknown and the outcome of the dizziness was not resolved. It was unknown if the reporter considered the syncope, injection site pain and dizziness to be related to Arexvy. The company considered the syncope to be unrelated to Arexvy. It was unknown if the company considered the injection site pain and dizziness to be related to Arexvy. Additional Information: GSK Receipt Date: 10-FEB-2025 The patient self-reported this case himself. The patient stated he received Arexvy in left arm. 3 hours later the patient had pain at injection site and he was dizzy. The patient reported he read the side effects and warnings and stated he had syncope, but never lost consciousness. The patient's pain in harm had subsided but the dizziness has not.; Sender's Comments: Syncope is an unlisted event which is considered unrelated to GSK vaccine Arexvy. More
2827154		F	MA	02/20/2025	COVID19	PFIZER\BIONTECH		COVID-19, Disease recurrence, Drug ineffective COVID-19, Disease recurrence, Drug ineffective	COVID after Pfizer COVID shots; COVID after Pfizer COVID shots; needed Paxlovid then, and need Paxlo... COVID after Pfizer COVID shots; COVID after Pfizer COVID shots; needed Paxlovid then, and need Paxlovid now; This is a spontaneous report received from a Consumer or other non HCP, Program ID:. An 82-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN), for covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID after Pfizer COVID shots"; DISEASE RECURRENCE (medically significant), outcome "unknown", described as "needed Paxlovid then, and need Paxlovid now". Therapeutic measures were taken as a result of drug ineffective, covid-19, disease recurrence. Clinical course: It was reported that about a year ago, patient was at another institution. She needed Paxlovid then and need Paxlovid now as prescribed by her doctor. This happened last time about a year ago. She got the Paxlovid at no charge. She is now in the same position and she need the Paxlovid, and that's why she was calling. She used Pfizer for all her COVID shots. At her age, she do that every 6 months about it. Once before, she used the Paxlovid, and it gave her helped her just have a really mild case of COVID and now she need it again. More
2827155	57	F		02/20/2025	COVID19	PFIZER\BIONTECH		COVID-19, Vaccination failure COVID-19, Vaccination failure	Patient was diagnosed with Covid-19 yesterday 15Feb; Patient was diagnosed with Covid-19 yesterday 1... Patient was diagnosed with Covid-19 yesterday 15Feb; Patient was diagnosed with Covid-19 yesterday 15Feb; This is a spontaneous report received from a Consumer or other non HCP from a sales representative. A 57-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 15Oct2024 as dose 1, single (Batch/Lot number: unknown) at the age of 57 years, in upper arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU [INFLUENZA VACCINE] (SEQIRUS) taken for immunisation as dose number unknown, sngle. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 15Feb2025, outcome "recovering" and all described as "Patient was diagnosed with Covid-19 yesterday 15Feb". The event "patient was diagnosed with covid-19 yesterday 15feb" required physician office visit. Therapeutic measures were not taken as a result of vaccination failure, covid-19. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2827156		F	MI	02/20/2025	COVID19	PFIZER\BIONTECH		COVID-19, Drug ineffective, Oropharyngeal pain, Sinusitis COVID-19, Drug ineffective, Oropharyngeal pain, Sinusitis	the second one I got COVID; the second one I got COVID; sore throat; sinus infection; This is a spon... the second one I got COVID; the second one I got COVID; sore throat; sinus infection; This is a spontaneous report received from a Consumer or other non HCP, Program ID:. A 69-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: Unknown), for COVID-19 immunization, reaction(s): "I got a lump in my throa--like on the side of my neck". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "the second one I got COVID"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; SINUSITIS (non-serious), outcome "unknown", described as "sinus infection". Clinical course: The patient stated that "This is the fourth time I have COVID, and you know I took the first injection, the first vaccination, and I got a lump in my throat--like on the side of my neck, and then the second one I got COVID, and then I had COVID twice with, my sister got it from her husband, and I got it from her, and today we went into the doctor's office because. she said you know, I have a sore throat, and I said, you know I have a little bit of a sore throat, but I think I have a sinus infection. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500019248 same patient and drug, different dose and event; More
2827168	50	M	AZ	02/20/2025	COVID19	MODERNA	041L20A	Infection, Leg amputation, Localised infection, Staphylococcal infection Infection, Leg amputation, Localised infection, Staphylococcal infection	I had Complex Regional Pain Syndrome (CRPS) since 2009. The condition was relatively stable, managed... I had Complex Regional Pain Syndrome (CRPS) since 2009. The condition was relatively stable, managed through leg braces and a Dorsal Root Ganglion spinal cord stimulator. Four months after the first COVID vaccination, I discovered a serious MRSA infection in the right foot and ankle. This was an unprecedented event. I did not have any issues with serious infections prior. Over the next two years, I developed further infections, and in October 2023, the leg braces suddenly became ineffective. My physicians decided that a below-the-knee amputation was necessary at that point, which I had done in January 2024. Just recently, I came across scientific data indicating that the COVID vaccinations can make the CRPS worse. Here is an example of one of the articles that I discovered: More	✓	✓
2827169	59	F	AZ	02/20/2025	VARZOS VARZOS	GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS	58160-0823-11 o 58160-0823-11 o	Abdominal pain upper, Headache, Influenza like illness, Injection site pain, Inj... Abdominal pain upper, Headache, Influenza like illness, Injection site pain, Injection site swelling; Pain, Rhinorrhoea More	Suffered from pain, swelling and redness at injection site for 2 days. In addition, flu like symptom... Suffered from pain, swelling and redness at injection site for 2 days. In addition, flu like symptoms began within 12 hours of vaccine including headache, body aches, severe runny nose, and stomach ache that lasted for at least 24 hours. More
2827170				02/20/2025	VARZOS	UNKNOWN MANUFACTURER	UNK	Herpes zoster, Pain, Pruritus, Vaccination failure Herpes zoster, Pain, Pruritus, Vaccination failure	Suspected vaccination failure; still got shingles later; This serious case was reported by a consume... Suspected vaccination failure; still got shingles later; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: still got shingles later). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: This case was reported by a patient via interactive digital media Consumer reported that she /he got the vaccine, but still got shingles later. They mostly had itchy spots on upper right torso. They were a little painful, but not terrible. The Doctor said patient got a light case because he/she had the vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. More
2827171				02/20/2025	VARZOS	GLAXOSMITHKLINE BIOLOGICALS	UNK	Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling	area is swollen and sore and pink; area is swollen and sore and pink; area is swollen and sore and p... area is swollen and sore and pink; area is swollen and sore and pink; area is swollen and sore and pink; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site swelling in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 16-FEB-2025, the patient received Shingrix. In FEB-2025, an unknown time after receiving Shingrix, the patient experienced injection site swelling (Verbatim: area is swollen and sore and pink), injection site pain (Verbatim: area is swollen and sore and pink) and injection site discoloration (Verbatim: area is swollen and sore and pink). The outcome of the injection site swelling, injection site pain and injection site discoloration were not reported. It was unknown if the reporter considered the injection site swelling, injection site pain and injection site discoloration to be related to Shingrix. It was unknown if the company considered the injection site swelling, injection site pain and injection site discoloration to be related to Shingrix. Additional Information: GSK Receipt Date: 17-FEB-2025 This case was reported by a patient via interactive digital media. The patient received Shingrix vaccine and the area was swollen, sore and pink. The reporter was this normal. More
2827266	41	M	MA	02/20/2025	COVID19	MODERNA		Coronary arterial stent insertion, Myocardial infarction Coronary arterial stent insertion, Myocardial infarction	Heart attack Heart attack	✓
2827267	4	M	VA	02/20/2025	DTAPIPV DTAPIPV DTAPIPV MMRV MMRV MMRV	SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC.	U7838AA U7838AA U7838AA Y014440 Y014440 Y014440	Bradykinesia, Decreased activity, Feeling cold, Immediate post-injection reactio... Bradykinesia, Decreased activity, Feeling cold, Immediate post-injection reaction, Influenza A virus test negative; Influenza B virus test negative, Lethargy, Pyrexia, SARS-CoV-2 test negative, Strabismus; Visual impairment, Yawning; Bradykinesia, Decreased activity, Feeling cold, Immediate post-injection reaction, Influenza A virus test negative; Influenza B virus test negative, Lethargy, Pyrexia, SARS-CoV-2 test negative, Strabismus; Visual impairment, Yawning More	My son was lethargic immediately following the vaccinations, on the car ride home. He seemed slow mo... My son was lethargic immediately following the vaccinations, on the car ride home. He seemed slow moving throughout the rest of the day. All seemed well the following days until Monday February 10, 2025 at 7:00am. He was yawning and laying around on the couch, despite just waking up. He wasn't playing with his toys like he typically does. He kept asking to snuggle and telling me he was cold. I had him lay down at 10:00am to try to take a nap. He slept until 10:45am and woke up cross eyed. He said "Mom, I see two of you." I immediately took him to the ER, since his eyes were staying crossed. When we arrived, his eyes slowly began to go back to normal but he was saying that the things on the wall were "moving". More
2827268	75	M	GA	02/20/2025	VARZOS	GLAXOSMITHKLINE BIOLOGICALS	4H79Y	Extra dose administered, No adverse event Extra dose administered, No adverse event	Patient had NO adverse events. Patient came into a shingles outreach event located at a senior cente... Patient had NO adverse events. Patient came into a shingles outreach event located at a senior center. Patient stated he needed a shingles vaccine. Patient answered questions appropriately. Patient filled out consent forms without difficulty. Patient stated he never had a shingles vaccine before. When patient was looked up in grits immunization records it stated no shingles vaccine was given. Shingles vaccine given after consent was signed by patient. Patient alone at this visit. When patient was later notified about an insurance question, wife stated he had already completed his shingles series. Patient had two grits accounts. One stated he had completed the 2 Shingrix vaccines. The other record stated he had none. Patient had received a third dose of Shingrix. When called on 2/19/25 patient had no side effects to report. More
2827269	54	M	IN	02/20/2025	FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3	SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR	u8465ca u8465ca u8465ca u8465ca u8465ca u8465ca u8465ca u8465ca u8465ca u8465ca	Acute coronary syndrome, Anion gap, Anxiety, Arthralgia, Back pain; Basophil cou... Acute coronary syndrome, Anion gap, Anxiety, Arthralgia, Back pain; Basophil count decreased, Basophil percentage, Blood calcium normal, Blood chloride normal, Blood creatinine increased; Blood electrolytes normal, Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea increased; Carbon dioxide normal, Cardiomegaly, Chest X-ray abnormal, Chest pain, Chronic kidney disease; Coma scale normal, Condition aggravated, Creatinine renal clearance decreased, Dyspnoea, Eosinophil count normal; Eosinophil percentage, Full blood count normal, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased; Hypertension, Lymphocyte count normal, Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal; Mean cell volume normal, Mean platelet volume normal, Monocyte count increased, Monocyte percentage increased, Myalgia; Neutrophil count normal, Neutrophil percentage decreased, Pain, Platelet count normal, Pleural effusion; Red blood cell count normal, Red cell distribution width increased, Renal function test abnormal, Troponin increased, White blood cell count normal More	Document Type: History and Physical Document Subject: History & Physical Note Performed By: ... Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on February 20, 2025 03:55 EST Verified By: MD on February 20, 2025 03:55 EST Encounter Info: Hospital, Observation, 02/19/25 - * Final Report * Chief Complaint chest pain History of Present Illness/Subjective This is a 54-year-old man with past medical history of hypertension, CAD, CKD stage II, heart failure with reduced ejection fraction of 39%, anxiety, diabetes mellitus, hyperlipidemia, obesity, OSA, and GERD. Also has a recent medical history of hospitalization first at Hospital, and subsequently a University Hospital in January 2025. Had received PCI with stenting x 2 with hospital, then presented to University Hospital where he was found to have a proximal LAD lesion requiring PCI and stenting. The aforementioned clinical course was complicated by development of pericardial effusion and Dressler syndrome. The patient was initiated on GDMT as well as colchicine, repeat echocardiogram showed decrease in size of pericardial effusion. He now presents to University Hospital on 2/20/2025. Primary complaints on presentation are surrounding accelerated blood pressure at home, noted to be systolically in the 160s. Patient had mid back pain radiating to the left shoulder with associated chest pain. Patient describes slight shortness of breath at the time of the event. Given his recent history of coronary event, he was concerned and presented to the emergency department for further evaluation. Pain now resolved at the time of evaluation. On initial evaluation, hemogram values relatively within normal limits. Electrolyte analysis within normal limits. Renal function analysis shows slight reduction in GFR from relative baseline. Troponin elevated at 148 x 2. Repeat pending. Vital signs show the patient to be afebrile, without sustained tachypnea or tachycardia, saturating suitably well, and slightly hypertensive throughout. Imaging was obtained showing small left-sided pleural effusion. At this time the patient will be placed in observation for ongoing evaluation and treatment. Review of Systems Constitutional: No fevers, no chills, no sweats Eyes: No changes in vision Ears, Nose, Mouth, Throat: No ear pain, no nasal congestion, no sore throat Respiratory: + Shortness of breath, no cough, no wheeze Cardiovascular: + Chest pain, no palpitations, no edema Gastrointestinal: No abdominal pain, no nausea, no vomiting, no diarrhea, no constipation Genitourinary: No frequency, no urgency, no dysuria, no hematuria Hematologic/Lymphatic: No bruising, no enlarged lymph nodes Allergic/Immunologic: No hives Endocrine: No cold intolerance, no heat intolerance, no polyuria, no polydipsia Musculoskeletal: + Arthralgia, + myalgia Skin: No rash, no pruritus Neurological: No headache, no focal weakness, no numbness Psychiatric: + Anxiety, no depression Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 36.7 �C (Oral) BP: 156/91 HR: 86 (Monitored) RR: 17 SpO2: 96% Oxygen Therapy: Room air Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Patient Height Current Height: 182.9 cm Constitutional: No acute distress Eyes: PERRLA, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: No acute respiratory distress, nonlabored respiratory pattern, no overt wheezing or stridor Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. Chest pain R07.9 Resolved at the time of evaluation, likely multifactorial in the setting of recent MI and Dressler syndrome as well as accelerated hypertension and increased afterload with increased myocardial demand. Continue antiplatelet therapy, colchicine, and will obtain limited echocardiogram to evaluate stability of pre-existing pericardial effusion and rule out any complications of known Dressler syndrome 2. Accelerated hypertension I10 Down trended since arrival, continue at home antihypertensive regimen, continue to trend, will provide IV PRNs as required. 3. Elevated troponin R79.89 148 x 2 on presentation, likely due to increased mismatch demand with underlying physiological stress in the setting of accelerated hypertension. Likely non-myocardial injury related elevation in troponin. Will continue to trend serial enzymes. 4. CAD (coronary artery disease) I25.10 Chest pain resolved at this time, continue GDMT with titration as appropriate 5. CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 Stable with slight reduction from relative baseline, avoid nephrotoxins as possible and continue to trend 6. HFrEF (heart failure with reduced ejection fraction) I50.20 relatively euvolemic continue GDMT with titration as appropriate, baseline ejection fraction 39% on most recent echocardiogram, small left pleural effusion noted, likely secondary to increased afterload. 7. Dressler syndrome I24.1 Continue colchicine, limited echocardiogram pending. 8. Anxiety F41.9 Continue appropriate anxiolytics 9. DM2 (diabetes mellitus, type 2) E11.9 Continue subcutaneous insulin via CDA protocol and carb controlled diet for tight glycemic control. Initiate baseline basal/bolus regimen as indicated by clinical course with appropriate titration, resume home oral agents/analogs as appropriate when nearing discharge. 10. HLD (hyperlipidemia) E78.5 stable on current statin regimen 11. Obesity E66.9 Would benefit from dietary and exercise modification following resolution of acute illness 12. OSA (obstructive sleep apnea) G47.33 continue CPAP as required/tolerated??????? 13. GERD (gastroesophageal reflux disease) K21.9 continue PPI??????? Code Status Full Code Chronic Problem List Acute coronary syndrome with high troponin Anxiety BMI 31.0-31.9,adult Chronic kidney disease (CKD), stage III (moderate) Chronic pain syndrome Cigarette nicotine dependence in remission CKD (chronic kidney disease) Coronary artery disease involving coronary bypass graft of native heart with unstable angina pectoris Cough Degenerative tear of medial meniscus of right knee Diabetes DM (diabetes mellitus), type 2, uncontrolled Encounter for long-term (current) use of medications Erectile dysfunction of organic origin Essential hypertension Fracture of nasal bones, initial encounter for open fracture Hx of opioid abuse Hypercholesterolemia Hypertension Hypogonadism male Knee effusion Knee osteoarthritis Low back pain Mass of tongue Mixed hyperlipidemia Nasal septal deviation Obesity Peripheral edema Preop examination Primary osteoarthritis of right knee (Mod MC, Mild PF) Renal calculus Right knee pain Shortness of breath Sleep apnea Tobacco use Tonsillar hypertrophy, unilateral Tonsillar mass Uvular hypertrophy Procedure/Surgical History ?History of back surgery ?throat Medications Home Medications (18) Active ALprazoLAM 1 mg oral tablet 1 mg = 1 Tablet, PRN, Orally, BID Aspirin Low Dose 81 mg oral delayed release tablet 81 mg = 1 Tablet, Orally, Daily atorvastatin 80 mg oral tablet 80 mg = 1 Tablet, Orally, At Bedtime BD Ultra-Fine Nano (4mm x 32G) Pen Needle Use 4 per day, Other, 4 Times Daily, Dispense QS for 30 days colchicine 0.6 mg oral tablet 0.6 mg = 1 Tablet, Orally, BID Dexcom G7 Receiver Use As Directed, Other, ONCE Dexcom G7 Sensor Use As Directed, Other, Unscheduled, Replace every 10 days fluticasone 50 mCg/inh nasal spray 100 mCg = 2 Spray, Nostrils, Both, Daily insulin lispro 100 units/mL injection 17 Units, Subcutaneous, TID, Admelog Vial isosorbide mononitrate 30 mg oral tablet, extended release 30 mg = 1 Tablet, Orally, QAM, do not crush or chew nitroGLYCerin 0.4 mg sublingual tablet 0.4 mg = 1 Tablet, PRN, Sublingually, Q5min, If chest pain not relieved in 5 minutes after first dose, seek immediate medical attention pantoprazole 40 mg oral delayed release tablet 40 mg = 1 Tablet, Orally, Daily prasugrel 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily sodium bicarbonate 650 mg oral tablet 1,300 mg = 2 Tablet, Orally, Daily Toprol-XL 50 mg oral tablet, extended release 50 mg = 1 Tablet, Orally, Daily, continue home medication torsemide 20 mg oral tablet 20 mg = 1 Tablet, Orally, Daily Tresiba (insulin degludec) FlexTouch (CONCENTRATED) 200 units/mL subcutaneous solution See Instructions, 40 Units QAM 20 Units QHS valsartan 40 mg oral tablet 20 mg = 0.5 Tablet, Orally, Daily Active Scheduled Inpatient Medications None Reported One-Time Medications Given 02/19/25 00:00:00 TO 02/20/25 03:54:32 aspirin, Tab, Chewable, 324 mg, Orally, ONCE, (1 DOSE 02/20/25 01:24:00) PRN Medications (0600 - 0559) from 02/19 - 02/20 None Reported Allergies No Known Medication Allergies Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Former use, quit more than 90 days ago. Employment/School DISABILITY Substance Abuse Past Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Anxiety: Mother. Apnea, sleep..: Father. COPD: Father. Cancer..: Mother. Depression: Mother. Diabetes mellitus type 2: Mother. Diabetes..: Father. Heart disease: Father. Hypertension..: Father. Kidney disease: Father. SOB (shortness of breath)..: Father. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 8 k/cumm (02/19/25 23:43:00) RBC: 4.77 million/cumm (02/19/25 23:43:00) Hgb: 13.9 GM/dL (02/19/25 23:43:00) Hct: 40.5 % (02/19/25 23:43:00) MCV: 85 fL (02/19/25 23:43:00) MCH: 29.2 pg (02/19/25 23:43:00) MCHC: 34.4 GM/dL (02/19/25 23:43:00) RDW: 15.3 % High (02/19/25 23:43:00) Platelet: 179 k/cumm (02/19/25 23:43:00) MPV: 9.7 fL (02/19/25 23:43:00) Neutrophils %: 52 % (02/19/25 23:43:00) Lymphocytes %: 35 % (02/19/25 23:43:00) Monocytes %: 10 % (02/19/25 23:43:00) Eosinophils %: 2 % (02/19/25 23:43:00) Basophils %: 0 % (02/19/25 23:43:00) Absolute Neutrophil: 4.1 k/cumm (02/19/25 23:43:00) Absolute Lymphocyte: 2.8 k/cumm (02/19/25 23:43:00) Absolute Monocyte: 0.8 k/cumm (02/19/25 23:43:00) Absolute Eosinophil: 0.2 k/cumm (02/19/25 23:43:00) Absolute Basophil: 0 k/cumm (02/19/25 23:43:00) Chemistry: Sodium SerPl QN: 139 mmol/L (02/19/25 23:43:00) Potassium SerPl QN: 3.5 mmol/L (02/19/25 23:43:00) Chloride SerPl QN: 103 mmol/L (02/19/25 23:43:00) Carbon Dioxide SerPl QN: 27 mmol/L (02/19/25 23:43:00) Anion Gap: 9 mmol/L (02/19/25 23:43:00) BUN SerPl QN: 27 mg/dL High (02/19/25 23:43:00) Creatinine SerPl QN: 1.41 mg/dL High (02/19/25 23:43:00) Estimated GFR (CKD-EPI, no race): 59 mL/min/1.73m2 Low (02/19/25 23:43:00) Estimated CRCL (CG): 78 mL/min (02/19/25 23:43:00) Glucose SerPl QN: 137 mg/dL High (02/19/25 23:43:00) Calcium Total SerPl QN: 9.9 mg/dL (02/19/25 23:43:00) Troponin-I High Sensitivity: 148 ng/L High (02/20/25 01:25:00) Diagnostics Radiology Results - Last 24 hours Across Visits 02/19/2025 23:57 - XR Chest PA or AP Portable IMPRESSION: Cardiomegaly. Small left pleural effusion. Thank you for consulting our team of subspecialty radiologists at Medical Group Radiology. Please contact us with any questions. Signature Line Electronically Signed on 02/20/25 03:55 EST ________________________________________________________ MD More	✓
2827270	58	F	IN	02/20/2025	FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3 FLU3	SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR	u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA u8486BA	Acute kidney injury, Acute respiratory failure, Alanine aminotransferase normal,... Acute kidney injury, Acute respiratory failure, Alanine aminotransferase normal, Anion gap, Aspartate aminotransferase normal; Asthenia, Basophil count increased, Basophil percentage, Blood albumin normal, Blood alkaline phosphatase normal; Blood bicarbonate increased, Blood bilirubin normal, Blood calcium normal, Blood chloride decreased, Blood creatinine increased; Blood culture negative, Blood glucose increased, Blood lactic acid decreased, Blood magnesium normal, Blood pH; Blood potassium normal, Blood sodium normal, Blood urea increased, Brain natriuretic peptide normal, Breath sounds abnormal; Carbon dioxide increased, Chest X-ray abnormal, Chronic kidney disease, Chronic obstructive pulmonary disease, Cold sweat; Coma scale normal, Condition aggravated, Cough, Creatinine renal clearance decreased, Dehydration; Dyspnoea, Embolism, Eosinophil count normal, Eosinophil percentage, Glomerular filtration rate decreased; Glycosylated haemoglobin increased, Haematocrit decreased, Haemoglobin decreased, Hyperglycaemia, Hypoxia; Influenza, Influenza A virus test positive, Influenza B virus test, Influenza virus test negative, International normalised ratio increased; Legionella test, Leukocytosis, Lymphocyte count increased, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal; Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume normal, Monocyte count increased, Monocyte percentage; Neutrophil count increased, Neutrophil percentage increased, Obesity, Oxygen saturation decreased, PCO2 increased; PO2 decreased, Platelet count increased, Procalcitonin increased, Productive cough, Protein total normal; Prothrombin time prolonged, Pyrexia, Red blood cell count decreased, Red cell distribution width increased, Respiratory tract congestion; SARS-CoV-2 test negative, Sepsis, Shift to the left, Sputum discoloured, Streptococcus test negative; Troponin increased, Wheezing, White blood cell count increased More	Document Type: Internal Medicine IP Progress Note Document Subject: Progress Note Comprehensive ... Document Type: Internal Medicine IP Progress Note Document Subject: Progress Note Comprehensive Performed By: NP on February 16, 2025 12:10 Verified By: NP on February 16, 2025 12:10 Encounter Info: Hospital, Inpatient, 02/12/25 - * Final Report * Document Contains Addenda Subjective Admission Date: 02/12/2025 09:02 LOS: 4 Days Patient is a 58-year-old female past history significant for COPD, hypertension, peripheral artery disease present emergency room increase embolus shortness of breath cough and congestion. Patient states that she has had several members in her household ill over the course of the weekend. 2 days ago she began noticing increased symptoms of cough and congestion. Over the last 24 to 48 hours she has noticed progressively worsening shortness of breath with progressive hypoxia initially she was saturating in the low 90 to 92% and then later in the low 84 to 85% range. She placed herself on 2 L of oxygen but her shortness of breath persisted. She tried using breathing treatments at home but they were only minimally relieving her with ongoing symptoms. She felt clammy at times but did not check her temperature but was found to be febrile by EMS. No symptoms of chest pain but she has had a productive cough that is been yellow in nature. No symptoms of myalgias or arthralgias noted. As her shortness of breath worsened and she progressively declined she present emergency room for further evaluation. In the emergency room: Blood pressure was 144/64 heart rate 106 respiratory rate 20 oxygen saturation was 85% on room air temperature 37.9 Serology: White count 18,900 with a left shift hemoglobin 12.2 hematocrit 36.7 and a platelet count of 402,000. INR 2.25 with a pro time of 25.3. Sodium 137 potassium 3.7 chloride 93 bicarb 32 BUN 18 creatinine 1.3 and a blood sugar of 135. Troponin 7 BNP 20 serum lactate 1.5 venous blood gas pH 7.41 pCO2 54 pO2 less than 35. COVID PCR negative. Influenza A PCR positive. Influenza B PCR negative. Chest x-ray showed no acute findings. Past medical history: Peripheral artery disease including celiac artery stenosis and mesenteric artery stenosis, hypertension, GERD status post Nissen fundoplication, history of CVA, iron deficiency anemia, ongoing tobacco use.??????? 2/13: Pts blood sugars elevated, borderline diabetic at baseline, added CDA protocol, Pt feels better but still not well. Bld cx pending, tapering steroids. Still on 4l nc 2/14: wbc went up again today , tapered her steroids again today. Still wheezy and coarse, RA is baseline and she is on 2l nc today down from 4l yesterday, She feels a little better but not ready to go home. 2/15: Feels fair. Oxygen intermittently. She has home oxygen, but "hasn't needed it for months". Occasional prod cough, sinus congestion. Feels weak after being up. IV came out. Multiple attempts to restart unsuccessful.??????? 2/16: Feels fair. Breathing a little better. Room air. Increased productive cough. No fever or chills. Worried about returning home and smoking again. WBC remains significantly elevated. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI??????? Objective Vitals and Measurements Vitals & Measurements most recent past 24 hours T: 36.4 �C (Oral) TMIN: 36.4 �C (Oral) TMAX: 36.7 �C (Oral) BP: 128/48 HR: 88 (Monitored) RR: 18 SpO2: 100% Oxygen Therapy: Room air Oxygen Flow Rate: 0 (L/min) Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 91.8 kg 02/13/25 Previous Daily Weight: 82.7 kg 02/12/25 Difference from Previous: 9.100 kg BMI: 30.3 02/12/25 Obese (BMI 30-39.9) Patient Height Current Height: 165.1 cm 02/13/25 Nutritional Orders: 2000 mg Sodium Diet, Start on: 02/13/25 15:28:00, 225 gm Carb per day, "No Fluid Restrictions" mL Nursing ---------------------- Intake/Output I/O TOTALS ONLY - Last 24 hrs (0600-0559) from 02/15 - 02/16 Total Intake 410.00 mL Total Output 0.00 mL Balance 410.00 mL Physical Exam Constitutional: No acute distress Eyes: PERRLA, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs dim bases, coarse with faint exp??????? wheezes Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Lines, Tubes, and Drains There are no active lines present. Assessment/Plan Orders (Last 12 Hours): ?XR Chest PA and Lateral, Routine, For: leukocytosis, influenza, 02/16/25 11:51:00 1. Influenza A J10.1 Patient presents with influenza A with acute respiratory failure. tamiflu started 2/12 Rt protocol -on 2l, wean as tolerated-- room air 2. Sepsis A41.9 Patient for feel sepsis physiology. Blood cultures x 2 no growth -Negative Urine for Legionella and strep antigens -Procal 0.16, 0.15 Repeat procal due to sig leukocytosis-- >0.07 3. Hyperglycemia R73.9 recheck a1c, 7/24 7.4% -started CDA protocol [1] 4. Acute respiratory failure J96.00 Secondary to COPD exacerbation due to influenza A and underlying potential pneumonia. Continue RT protocol. Frequent nebulizer treatments and treatment of underlying infection. [2] 5. COPD exacerbation J44.1 Noted. Secondary to influenza A. Frequent nebulizer treatments. RT protocol with IV Solu-Medrol. Expectorant therapy. Oxygen therapy to maintain saturations above 90% with close follow-up. [3] 6. GERD (gastroesophageal reflux disease) K21.9 Continue reflux precautions and PPI therapy. 7. Hypertension I10 Noted. Blood pressure mains stable this time. Titrating patient's home medical regimen accordingly. [5] 8. Acute kidney injury superimposed on chronic kidney disease N17.9 Patient has acute on chronic kidney injury secondary to most likely prerenal azotemia from dehydration. She was started on judicious IV fluid rehydration and monitor renal function closely. Should correct fairly quickly. ??????? [6] ??????? Improving 9. Leukocytosis D72.829 continue abx and wean steroids, monitor for improvement daily -Bld cx negative. Only slight improvement, afebrile, neg procal Will repeat CXR Iron deficiency anemia D50.9 Stable at this time. Will continue to trend hemoglobin levels and transfuse if hemoglobin drops below 7. [7] PAD (peripheral artery disease) I73.9 Noted. Continue patient's baseline anticoagulation and ongoing risk factor modification. [8] Tobacco use Z72.0 Patient needs to stop smoking. Options and prescription medications were discussed and offered to the patient at this time Discussed strategies to quit Admission Disposition Fluids: saline locked Lines: PIV Diet: Diabetic Carb Controlled Code Status/Goals of Care Discussion: Full Code VTE ppx: Lovenox Sub Q Dispo: Home No Needs Anticipated Length of stay on admission: Greater than 2 midnights??????? Discharge Disposition: _Expect the patient to be medically ready for discharge in tomorrow???????, pending patient vital signs (HR/BP/RR/T) are within stable discharge parameters Location: Plan for discharge to be determined after therapy evaluations Discharge Needs: None, Discharge therapy (PT/OT/ST) recommendations Case Management Engaged Code Status Resuscitation Status - Ordered -- 02/12/25 13:09:00, Full Code Medications Active Scheduled Inpatient Medications albuterol-ipratropium (albuterol-ipratropium inh soln 2.5 mg-0.5 mg/3 mL), Inhalation SOLN, 3 mL, Neb Inhale, Q6H, Start: 02/14/25 13:00:00 apixaban, Tablet, 5 mg, Orally, BID, Start: 02/12/25 21:00:00 cefPODOXime, Tablet, 400 mg, Orally, BID, Indication: COPD Exacerbation, Start: 02/15/25 21:00:00 doxycycline, Capsule, 100 mg, Orally, BID, Indication: Pneumonia - CAP, Start: 02/12/25 22:00:00 guaiFENesin (Mucinex 600 mg oral tablet, extended release), Tab, Extended Rel, 600 mg, Orally, BID, Start: 02/12/25 21:00:00 hydroCHLOROthiazide (hydroCHLOROthiazide (HCTZ) 12.5 mg oral capsule), Tablet, 12.5 mg, Orally, Daily, Start: 02/14/25 09:00:00 lisinopril, Tablet, 10 mg, Orally, Daily, Start: 02/14/25 09:00:00 oseltamivir (Tamiflu), Capsule, 30 mg, Orally, BID, Indication: Influenza Treatment, Start: 02/12/25 21:00:00 pantoprazole, Tab, Delayed Rel, 40 mg, Orally, Daily, Start: 02/13/25 09:00:00 predniSONE, Tablet, 20 mg, Orally, Daily, Start: 02/16/25 09:00:00 Dextrose 10% in Water 500 mL IV Continuous PRN interruption in TF/TPN at 80 mL/hr, per CDA One-Time Medications Given 02/15/25 00:00:00 TO 02/16/25 12:10:38 None Reported PRN Medications (0600 - 0559) from 02/15 - 02/16 OXYcodone-acetaminophen, 1 Tablet, Orally, Q8H, 0 Dose(s) acetaminophen, 1,000 mg, Orally, Q8H, 0 Dose(s) acetaminophen, 650 mg, Orally, Q4H, 0 Dose(s) albuterol, 2.5 mg, Neb Inhale, Q2H, 0 Dose(s) glucagon, 1 mg, IM, Unscheduled, 0 Dose(s) glucose, Per Core Diabetes App , IV Push, Unscheduled, 0 Dose(s) hydroCODONE-acetaminophen, 1 Tablet, Orally, Q8H, 2 Dose(s) insulin lispro, Per Core Diabetes App , Subcutaneous, Unscheduled, 4 Dose(s) magnesium sulfate, 2 GM, IVPB, Q12H, 0 Dose(s) magnesium sulfate, 4 GM, IVPB, Q12H, 0 Dose(s) ondansetron, 4 mg, IV Push, Q6H, 0 Dose(s) polyethylene glycol 3350, 17 GM, Orally, Daily, 1 Dose(s) potassium chloride, 20 mEq, Orally, Unscheduled, 0 Dose(s) potassium chloride, 30 mEq, Orally, Unscheduled, 0 Dose(s) potassium chloride, 40 mEq, Orally, Unscheduled, 0 Dose(s) Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 29.6 k/cumm High (02/16/25 02:09:00) RBC: 4.1 million/cumm (02/16/25 02:09:00) Hgb: 11.5 GM/dL Low (02/16/25 02:09:00) Hct: 35.1 % (02/16/25 02:09:00) MCV: 86 fL (02/16/25 02:09:00) MCH: 28 pg (02/16/25 02:09:00) MCHC: 32.7 GM/dL (02/16/25 02:09:00) RDW: 14.8 % High (02/16/25 02:09:00) Platelet: 621 k/cumm High (02/16/25 02:09:00) MPV: 7.5 fL (02/16/25 02:09:00) Neutrophils %: 76 % (02/16/25 02:09:00) Lymphocytes %: 14 % (02/16/25 02:09:00) Monocytes %: 8 % (02/16/25 02:09:00) Eosinophils %: 1 % (02/16/25 02:09:00) Basophils %: 1 % (02/16/25 02:09:00) Absolute Neutrophil: 22.4 k/cumm High (02/16/25 02:09:00) Absolute Lymphocyte: 4.1 k/cumm High (02/16/25 02:09:00) Absolute Monocyte: 2.4 k/cumm High (02/16/25 02:09:00) Absolute Eosinophil: 0.4 k/cumm High (02/16/25 02:09:00) Absolute Basophil: 0.2 k/cumm (02/16/25 02:09:00) Chemistry: Sodium SerPl QN: 136 mmol/L (02/16/25 02:09:00) Potassium SerPl QN: 5 mmol/L (02/16/25 02:09:00) Chloride SerPl QN: 99 mmol/L (02/16/25 02:09:00) Carbon Dioxide SerPl QN: 30 mmol/L High (02/16/25 02:09:00) Anion Gap: 7 mmol/L (02/16/25 02:09:00) BUN SerPl QN: 33 mg/dL High (02/16/25 02:09:00) Creatinine SerPl QN: 1.29 mg/dL High (02/16/25 02:09:00) Estimated GFR (CKD-EPI, no race): 48 mL/min/1.73m2 Low (02/16/25 02:09:00) Estimated CRCL (CG): 54 mL/min Low (02/16/25 02:09:00) Glucose SerPl QN: 202 mg/dL High (02/16/25 02:09:00) Calcium Total SerPl QN: 9.6 mg/dL (02/16/25 02:09:00) Alkaline Phos SerPl QN: 61 Units/L (02/16/25 02:09:00) ALT SerPl QN: 8 Units/L (02/16/25 02:09:00) AST SerPl QN: 13 Units/L (02/16/25 02:09:00) Bilirubin Total SerPl QN: 0.3 mg/dL (02/16/25 02:09:00) Total Protein SerPl QN: 6.6 GM/dL (02/16/25 02:09:00) Albumin SerPl QN: 3.9 GM/dL (02/16/25 02:09:00) Magnesium SerPl QN: 2.1 mg/dL (02/16/25 02:09:00) Gluc-Strip, POC: 176 mg/dL High (02/16/25 11:31:00) All Other Labs: Procalcitonin: 0.07 ng/mL (02/15/25 12:42:00) Micro - Last 7 days L pneumo Urine Ag QL: Not Detected (02/13/25 06:16:00) L pneumo Urine Ag QL Interp: L pneumo Urine Ag QL Interp (02/13/25 06:16:00) Strep pneumo Ag Ur: GeneXpert NOT DETECTED (02/13/25 06:16:00) Strep pneumo Ag Ur Interp: Strep pneumo Ag Ur Interp (02/13/25 06:16:00) Rapid Influenza Method: PCR - Liat (02/12/25 09:16:00) Rapid Influenza A PCR: Detected Abnormal (02/12/25 09:16:00) Rapid Influenza B PCR: Not Detected (02/12/25 09:16:00) Diagnostics Radiology Results - Last 24 hours Across Visits No radiology results found in the last 24 hours. Signature Line Electronically Signed on 02/16/25 12:10 ________________________________________________________ NP Addendum by MD on February 16, 2025 18:43:39 (Verified) I saw and evaluated the patient in addition to NP. I provided a substantive portion of the care for this patient. I personally performed in its entirety the history, exam and medical decision making for this encounter. I have reviewed and verified this documentation and it accurately reflects our care. General: Alert and oriented, No acute distress. Eyes: Extraocular movements are intact, no scleral icterus HEENT: Normocephalic, Normal hearing, Moist oral mucosa Respiratory: Lungs are clear to auscultation, Respirations are non-labored, Breath sounds are equal, No chest wall tenderness. Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, nontender, nondistended, normal bowel sounds Musculoskeletal: intact ROM Integumentary: no rashes Neurologic: Alert, no focal deficits Psychiatric: Cooperative, appropriate mood and affect MD Signature Line Electronically Signed on 02/16/25 18:43 ________________________________________________________ MD More	✓
2827271	72	F	FL	02/20/2025	RSV	GLAXOSMITHKLINE BIOLOGICALS	jb27a	Extra dose administered, No adverse event Extra dose administered, No adverse event	Received a second RSV vaccine. No adverse reactions to report, unremarkable. Received a second RSV vaccine. No adverse reactions to report, unremarkable.
2827272	32	F	NC	02/20/2025	HEP TDAP	GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR	3CA10C1 CT3Z7	Pharyngeal hypoaesthesia, Rash, Urticaria; Pharyngeal hypoaesthesia, Rash, Urtic... Pharyngeal hypoaesthesia, Rash, Urticaria; Pharyngeal hypoaesthesia, Rash, Urticaria More	Patient received Tdap and Hep B vaccine in clinic and reported that her throat started going numb wi... Patient received Tdap and Hep B vaccine in clinic and reported that her throat started going numb within 5 minutes of receiving immunizations and also reported breaking out in hives to her right arm. This occured while patient was still in cilnic and diphenhydramine administered after medical director notified. No visible discoloration to skin noted by nursing staff. Patient reports she was seen in urgent care the next day and given steroids because she had broken out in "polka dot" rash - rash resolved within 4 days of steroids. More
2827273	32	M	OH	02/20/2025	PNC20	PFIZER\WYETH		Blood pressure increased, Chest pain, Hyperhidrosis Blood pressure increased, Chest pain, Hyperhidrosis	Rapid Heart Rate over 110, Elevated BP, profuse sweating, chest pain Rapid Heart Rate over 110, Elevated BP, profuse sweating, chest pain
2827274	60	M	NY	02/20/2025	PNC20	PFIZER\WYETH	LK650	Atrial fibrillation, Electrocardiogram abnormal Atrial fibrillation, Electrocardiogram abnormal	Atrial fibrillation Atrial fibrillation
2827275	46	M	FL	02/20/2025	HEP	DYNAVAX TECHNOLOGIES CORPORATION	945660	Unevaluable event Unevaluable event	None None
2827276	40	F	MO	02/20/2025	COVID19 COVID19 COVID19	MODERNA MODERNA MODERNA	025J20-2A 042L20A 030H21B	Amnesia, Brain fog; Amnesia, Brain fog; Amnesia, Brain fog Amnesia, Brain fog; Amnesia, Brain fog; Amnesia, Brain fog	BRAIN FOG, MEMORY LOSS BRAIN FOG, MEMORY LOSS		✓

‹ Previous Page 577 of 682 Next ›

🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

Data Source & Accuracy

Your Privacy

Medical Disclaimer

Data Interpretation

📖 Help & Search Guide

Column Icons Legend

How to Search

Understanding the Data

Using the Table

💡 Frequently Asked Questions (FAQ)

What is this site?

What is VAERS?

Is this data HIPAA compliant?

Why does this site exist?

Where does the data come from?

My vaccine lot number matches one with deaths/serious events - should I be worried?

Can I trust VAERS data?

What are "adverse events"?

Why are some lot numbers listed multiple times?

How often is this data updated?

Where can I learn more?